These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1702539)

  • 1. First-trimester maternal serum alpha-fetoprotein and human chorionic gonadotropin screening for chromosome defects.
    Nebiolo L; Ozturk M; Brambati B; Miller S; Wands J; Milunsky A
    Prenat Diagn; 1990 Sep; 10(9):575-81. PubMed ID: 1702539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
    Milunsky A; Wands J; Brambati B; Bonacchi I; Currie K
    Am J Obstet Gynecol; 1988 Nov; 159(5):1209-13. PubMed ID: 2461080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
    Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
    Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum screening in Ontario using the triple marker test.
    Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
    J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
    Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
    Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
    Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
    Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
    BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester alpha-fetoprotein screening for Down syndrome.
    Fuhrmann W; Altland K; Jovanovic V; Holzgreve W; Miny P; Wenger D; Rauskolb R
    Prenat Diagn; 1993 Mar; 13(3):215-8. PubMed ID: 7685089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
    Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?
    Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC
    Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.